| Literature DB >> 32509152 |
Yiwen Liu1, Chifa Ma1, Pingping Li2,3, Chunxiao Ma2,3, Shuli He4, Fan Ping1, Huabing Zhang1, Wei Li1, Lingling Xu1, Yuxiu Li1.
Abstract
It remains unknown how different glucose tolerance status affects the relationships between dietary intake of different tocopherol isoforms (α-, β-, γ-, and δ-tocopherol) and cellular aging, oxidative stress, and inflammatory markers. The authors conducted a cross-sectional study among 582 Chinese adults with different glucose tolerance status to explore the association between dietary intake of different tocopherol isoforms and cellular aging, oxidative stress, and inflammatory markers. The inverse correlations between non-α-tocopherols and tumor necrosis factor-alpha (TNF-α) varied substantially across different glucose tolerance status, with the strongest observed in prediabetes (r = -0.33 for β-/γ-tocopherol, r = -0.37 for δ-tocopherol, p < 0.01), followed by normal glucose tolerance (NGT). While such correlations were abolished in established diabetes. Furthermore, within prediabetes, the strongest inverse correlations between non-α-tocopherols and TNF-α were observed in impaired fasting glucose (IFG) (r = -0.42 for β-/γ-tocopherol, r = -0.55 for δ-tocopherol, p < 0.01), while such correlations were significantly attenuated in individuals with impaired glucose tolerance (IGT) and IFG+IGT. And mediation model analysis displayed that TNF-α mediated the protective effect of non-α-tocopherols on leukocyte telomere length and mitochondrial DNA copy number, which was uniquely observed in prediabetes, while such mediation effect was statistically nonsignificant in NGT and established diabetes. In conclusion, our findings indicate that dietary intake of non-α-tocopherols might protect against cellular aging markers mediated by TNF-α in prediabetes. Individuals with prediabetes, especially for IFG, might benefit from increasing dietary intake of non-α-tocopherol in alleviating inflammation and cellular aging, which might provide a new dietary avenue for delaying diabetes onset.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32509152 PMCID: PMC7245674 DOI: 10.1155/2020/7396801
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Difference of clinical characteristics of individuals with different glucose tolerance status.
| NGT ( | Pre-DM ( | DM ( |
| |
|---|---|---|---|---|
| Gender (M/F) | 168/78 | 106/68 | 103/59 | 0.277 |
| Age (years) | 49.41 ± 11.64 | 56.41 ± 10.68a | 56.85 ± 10.08a | <0.001 |
| BMI (kg/m2) | 25.23 ± 3.58 | 26.63 ± 3.62a | 26.40 ± 3.81a | <0.001 |
| WC (cm) | 85.19 ± 9.53 | 88.77 ± 9.00a | 88.50 ± 9.77a | <0.001 |
| HC (cm) | 90.58 ± 9.62 | 94.42 ± 8.99a | 93.80 ± 12.44a | <0.001 |
| SBP (mmHg) | 124.55 ± 17.07 | 128.75 ± 15.89a | 132.19 ± 19.08a | <0.001 |
| DBP (mmHg) | 75.96 ± 9.41 | 75.97 ± 10.21 | 76.81 ± 10.48 | 0.654 |
| HbA1c (%) | 5.41 ± 0.53 | 5.71 ± 0.38a | 7.25 ± 1.57a,b | <0.001 |
| FPG (mmol/L) | 5.53 (5.25, 5.81) | 6.22 (5.87, 6.50)a | 8.41 (7.26, 10.17)a,b | <0.001 |
| 2hPG (mmol/L) | 6.11 (5.17, 7.15) | 8.04 (6.78, 9.30)a | 15.43 (11.71, 19.42)a,b | <0.001 |
| FINS ( | 8.93 (6.62, 12.23) | 9.77 (7.24, 13.84) | 11.38 (7.38, 17.55)a | <0.001 |
| 2hINS ( | 34.70 (19.36, 52.84) | 54.47 (36.07, 79.47)a | 46.92 (25.94, 86.65)a | <0.001 |
| FCP (ng/mL) | 1.20 (0.94, 1.55) | 1.38 (1.15, 1.91)a | 1.44 (0.96, 2.02)a | <0.001 |
| 2hCP (ng/mL) | 4.62 (3.33, 5.89) | 6.29 (4.66, 8.18) | 5.19 (3.25, 7.40)a,b | <0.001 |
| UA ( | 280.99 ± 76.93 | 308.66 ± 86.51a | 289.18 ± 75.87 | 0.002 |
| TC (mmol/L) | 5.30 ± 0.95 | 5.61 ± 1.05a | 5.46 ± 1.16 | 0.013 |
| TG (mmol/L) | 1.22 (0.82, 1.61) | 1.53 (1.08, 2.28)a | 1.72 (1.17, 2.37)a | <0.001 |
| HDL-C (mmol/L) | 1.32 ± 0.27 | 1.28 ± 0.26 | 1.24 ± 0.27a | 0.023 |
| LDL-C (mmol/L) | 2.69 ± 0.71 | 2.96 ± 0.69a | 2.87 ± 0.73a | <0.001 |
a p < 0.05 compared with NGT. bp < 0.05 compared with pre-DM. Abbreviations: NGT—normal glucose tolerance; pre-D—prediabetes; DM—diabetes mellitus; BMI—body mass index; WC—waist circumference; HC—hip circumference; SBP—systolic blood pressure; DBP—diastolic blood pressure; HbA1c—glycosylated hemoglobin; FPG—fasting plasma glucose; 2hPG—2 h postload plasma glucose; FINS—fasting insulin; 2hINS—2 h postload insulin; FCP—fasting C-peptide; 2hCP—2 h postload C-peptide; UA—uric acid; TC—total cholesterol; TG—total triglyceride; HDL-C—high-density lipoprotein cholesterol; LDL-C—low-density lipoprotein cholesterol.
Figure 1Comparison of cellular aging, oxidative stress, and inflammatory markers among different glucose tolerance status. The differences of cellular aging, oxidative stress, and inflammatory markers did not reach statistical significance (p > 0.05). Abbreviations: NGT—normal glucose tolerance; pre-DM—prediabetes; DM—diabetes mellitus; LTL—leukocyte telomere length; mtDNAcn—mitochondrial DNA copy number; TNF-α—tumor necrosis factor-α; IL-6—interleukine-6; SOD—superoxide dismutase; GR—glutathione reductase
Figure 2Comparison of dietary intake of total Toc and different Toc isoforms among different glucose tolerance status. The differences of dietary intake of total Toc and different Toc isoforms did not reach statistical significance (p > 0.05). Abbreviations: NGT—normal glucose tolerance; pre-DM—prediabetes; DM—diabetes mellitus; Toc—tocopherol(s)
Spearman's correlations of different Toc isoforms with markers of cellular aging, oxidative stress, and inflammation in various glucose tolerance status.
| Total Toc |
|
|
| |
|---|---|---|---|---|
| NGT ( | ||||
| LTL | 0.15∗ | -0.19∗∗ | 0.16∗ | 0.18∗∗ |
| mtDNAcn | 0.11 | -0.12 | 0.13∗ | 0.13∗ |
| TNF- | -0.21∗∗ | 0.20∗∗ | -0.22∗∗ | -0.28∗∗ |
| IL-6 | -0.03 | 0.02 | -0.04 | -0.03 |
| 8-OHdG | 0.04 | -0.04 | 0.04 | 0.06 |
| SOD | -0.10 | 0.24∗∗ | -0.13∗ | -0.23∗∗ |
| GR | 0.00 | 0.03 | 0.03 | 0.01 |
| Pre-DM ( | ||||
| LTL | 0.11 | -0.30∗∗ | 0.14 | 0.16∗ |
| mtDNAcn | 0.04 | -0.19∗ | 0.06 | 0.08 |
| TNF- | -0.32∗∗ | 0.19∗ | -0.33∗∗ | -0.37∗∗ |
| IL-6 | 0.02 | 0.15∗ | -0.01 | -0.05 |
| 8-OHdG | -0.11 | 0.07 | -0.12 | -0.10 |
| SOD | -0.13 | 0.11 | -0.14 | -0.17∗ |
| GR | 0.06 | 0.08 | 0.05 | 0.03 |
| DM ( | ||||
| LTL | 0.13 | -0.18∗ | 0.14 | 0.20∗ |
| mtDNAcn | -0.05 | -0.02 | -0.05 | -0.05 |
| TNF- | -0.08 | 0.10 | -0.12 | -0.11 |
| IL-6 | 0.09 | 0.10 | 0.07 | 0.09 |
| 8-OHdG | -0.11 | -0.10 | -0.10 | -0.05 |
| SOD | -0.05 | 0.15 | -0.07 | -0.06 |
| GR | 0.03 | -0.03 | 0.02 | 0.04 |
∗ p < 0.05 and ∗∗p < 0.01. Abbreviations: NGT—normal glucose tolerance; pre-DM—prediabetes; DM—diabetes mellitus; Toc—tocopherol(s); LTL—leukocyte telomere length; mtDNAcn—mitochondrial DNA copy number; TNF-α—tumor necrosis factor-α; IL-6—interleukine-6; SOD—superoxide dismutase; GR—glutathione reductase.
Spearman correlations of different Toc isoforms with markers of cellular aging, oxidative stress, and inflammation in different groups of prediabetic individuals.
| Total Toc |
|
|
| |
|---|---|---|---|---|
| IFG ( | ||||
| LTL | 0.23 | -0.39∗∗ | 0.26∗ | 0.27∗ |
| mtDNAcn | 0.18 | -0.37∗∗ | 0.20 | 0.39∗∗ |
| TNF- | -0.39∗∗ | 0.35∗∗ | -0.42∗∗ | -0.55∗∗ |
| IL-6 | -0.02 | 0.17 | -0.10 | -0.11 |
| 8-OHdG | 0.12 | 0.04 | 0.14 | 0.13 |
| SOD | -0.05 | -0.04 | -0.04 | -0.10 |
| GR | 0.02 | -0.02 | 0.04 | 0.01 |
| IGT ( | ||||
| LTL | 0.05 | -0.18 | 0.06 | 0.09 |
| mtDNAcn | 0.10 | -0.12 | 0.12 | 0.02 |
| TNF- | -0.26∗ | -0.06 | -0.27∗ | -0.21 |
| IL-6 | 0.05 | 0.07 | -0.01 | -0.00 |
| 8-OHdG | -0.20 | 0.09 | -0.24 | -0.08 |
| SOD | -0.12 | 0.12 | -0.09 | -0.11 |
| GR | 0.11 | 0.07 | 0.06 | 0.03 |
| IFG+IGT ( | ||||
| LTL | 0.00 | -0.35∗ | -0.00 | 0.07 |
| mtDNAcn | -0.22 | -0.10 | -0.20 | -0.27 |
| TNF- | -0.25 | 0.24 | -0.25 | -0.23 |
| IL-6 | 0.04 | 0.20 | 0.07 | -0.01 |
| 8-OHdG | -0.40∗∗ | 0.12 | -0.38∗∗ | -0.44∗∗ |
| SOD | -0.28 | 0.21 | -0.31∗ | -0.25 |
| GR | 0.02 | 0.21 | 0.03 | 0.08 |
∗ p < 0.05 and ∗∗p < 0.01. Abbreviations: Toc—tocopherol(s); IFG—impaired fasting glucose; IGT—impaired glucose tolerance; LTL—leukocyte telomere length; mtDNAcn—mitochondrial DNA copy number; TNF-α—tumor necrosis factor-α; IL-6—interleukine-6; SOD—superoxide dismutase; GR—glutathione reductase.
Univariate and multivariate linear regression analyses of different Toc isoforms with cellular aging, oxidative stress, and inflammatory markers in prediabetic individuals.
| LTL | mtDNAcn | TNF- | Log2 (IL-6) | Log2 (8-OHdG) | SOD | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Univariate linear regression model | ||||||||||||
| Total Toc | 0.001 | 0.511 | 0.131 | 0.220 | -0.110 | <0.001 | -0.001 | 0.700 | -0.005 | 0.155 | -0.012 | 0.789 |
|
| -0.0216 | 0.086 | -0.787 | 0.215 | 0.301 | 0.089 | 0.018 | 0.269 | 0.019 | 0.330 | 0.303 | 0.261 |
|
| 0.010 | 0.015 | 0.489 | 0.018 | -0.262 | <0.001 | -0.003 | 0.596 | -0.009 | 0.142 | -0.050 | 0.573 |
|
| 0.021 | 0.001 | 0.938 | 0.005 | -0.478 | <0.001 | -0.009 | 0.286 | -0.014 | 0.166 | -0.113 | 0.432 |
| Multivariate linear regression model | ||||||||||||
| Total Toc | <0.001 | 0.978 | 0.144 | 0.186 | -0.111 | <0.001 | -0.002 | 0.378 | -0.005 | 0.178 | -0.007 | 0.861 |
|
| -0.016 | 0.188 | -0.868 | 0.187 | 0.291 | 0.109 | 0.019 | 0.225 | 0.018 | 0.382 | -0.551 | 0.044 |
|
| 0.005 | 0.222 | 0.559 | 0.010 | -0.254 | <0.001 | -0.004 | 0.427 | -0.009 | 0.174 | -0.024 | 0.779 |
|
| 0.011 | 0.063 | 1.051 | 0.003 | -0.458 | <0.001 | -0.009 | 0.295 | -0.016 | 0.142 | -0.065 | 0.634 |
Multivariate linear regression model adjusted for age, BMI, SBP, DBP, HbA1c, FPG, PG120, UA, TC, TG, HDL-C, and LDL-C as covariates. Abbreviations: Toc—tocopherol(s); LTL—leukocyte telomere length; mtDNAcn—mitochondrial DNA copy number; TNF-α—tumor necrosis factor-α; IL-6—interleukine-6; SOD—superoxide dismutase; GR—glutathione reductase.
Figure 3Mediation model of association among (a) δ-Toc, TNF-α, and mtDNAcn; (b) β-/γ-Toc, TNF-α, and mtDNAcn; (c) δ-Toc, TNF-α, and LTL; (d) β-/γ-Toc, TNF-α, and LTL; (e) δ-Toc, HbA1c, and LTL; and (f) β-/γ-Toc, HbA1c, and LTL in prediabetic individuals. Zero that is not included in the 95% CI represents statistical significance. Abbreviations: Toc—tocopherol(s); LTL—leukocyte telomere length; mtDNAcn—mitochondrial DNA copy number; TNF-α—tumor necrosis factor-α; HbA1c—glycosylated hemoglobin.